{"id":"https://openalex.org/W2333201006","doi":"https://doi.org/10.1158/1541-7786.mcr-14-0314","title":"Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary","display_name":"Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary","publication_year":2014,"publication_date":"2014-12-18","ids":{"openalex":"https://openalex.org/W2333201006","doi":"https://doi.org/10.1158/1541-7786.mcr-14-0314","mag":"2333201006","pmid":"https://pubmed.ncbi.nlm.nih.gov/25519148","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4398602"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.mcr-14-0314","doi":"https://doi.org/10.1158/1541-7786.mcr-14-0314","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-14-0314","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4398602","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051651036","display_name":"Tomoyuki Sasano","orcid":"https://orcid.org/0000-0003-3754-475X","observed_orcids":["https://orcid.org/0000-0003-3754-475X","https://orcid.org/0000-0003-2772-0756"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoyuki Sasano","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090684583","display_name":"Seiji Mabuchi","orcid":"https://orcid.org/0000-0003-1803-1166","observed_orcids":["https://orcid.org/0000-0003-1803-1166","https://orcid.org/0000-0001-5570-0491"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Seiji Mabuchi","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062683030","display_name":"Hiromasa Kuroda","orcid":"https://orcid.org/0000-0003-4300-5517","observed_orcids":["https://orcid.org/0000-0003-4300-5517"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromasa Kuroda","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103111138","display_name":"Mahiru Kawano","orcid":"https://orcid.org/0000-0002-9495-1442","observed_orcids":["https://orcid.org/0000-0002-9495-1442"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mahiru Kawano","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109329600","display_name":"Yuri Matsumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuri Matsumoto","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102730905","display_name":"Ryoko Takahashi","orcid":"https://orcid.org/0000-0003-0397-4575","observed_orcids":["https://orcid.org/0000-0003-0397-4575"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryoko Takahashi","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112093553","display_name":"Takeshi Hisamatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Hisamatsu","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006897018","display_name":"Kenjiro Sawada","orcid":"https://orcid.org/0000-0001-7384-2581","observed_orcids":["https://orcid.org/0000-0001-7384-2581"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenjiro Sawada","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008483463","display_name":"Kae Hashimoto","orcid":"https://orcid.org/0000-0002-5836-9359","observed_orcids":["https://orcid.org/0000-0002-5836-9359"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kae Hashimoto","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110199877","display_name":"Aki Isobe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Aki Isobe","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014868247","display_name":"Joseph R. Testa","orcid":"https://orcid.org/0000-0003-1301-5175","observed_orcids":["https://orcid.org/0000-0003-1301-5175"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph R. Testa","raw_affiliation_strings":["2Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101777383","display_name":"Tadashi Kimura","orcid":"https://orcid.org/0000-0002-4391-6866","observed_orcids":["https://orcid.org/0000-0002-4391-6866"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadashi Kimura","raw_affiliation_strings":["1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090684583"],"corresponding_institution_ids":["https://openalex.org/I98285908"],"apc_list":null,"apc_paid":null,"fwci":2.2934,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.89527374,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"13","issue":"4","first_page":"795","last_page":"806"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.8059999942779541},{"id":"https://openalex.org/keywords/perifosine","display_name":"perifosine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.7839999794960022},{"id":"https://openalex.org/keywords/mtorc1-signaling","display_name":"mTORC1 signaling","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/bevacizumab-resistance","display_name":"bevacizumab resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.48500001430511475},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/serous-adenocarcinoma","display_name":"serous adenocarcinoma","score":0.8009999990463257},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.8157610893249512},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6688475012779236},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6637907028198242},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6448652744293213},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6188076138496399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5494571924209595},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.535362958908081},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.4380817413330078},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.41093355417251587},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3820946216583252},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3448774814605713},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3400009572505951},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3094019889831543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3045060336589813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2563821077346802},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076222","descriptor_name":"Mechanistic Target of Rapamycin Complex 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046912","descriptor_name":"Multiprotein Complexes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1541-7786.mcr-14-0314","doi":"https://doi.org/10.1158/1541-7786.mcr-14-0314","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-14-0314","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},{"id":"pmid:25519148","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25519148","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer research : MCR","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4398602","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4398602","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Res","raw_type":"Text"},{"id":"mag:2916654297","doi":null,"is_oa":false,"landing_page_url":"https://ir.library.osaka-u.ac.jp/repo/ouka/all/55833/28213_%E8%A6%81%E6%97%A8.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4398602","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4398602","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8078502187","display_name":"Basis for Lymphomagenesis in Akt2 Transgenic Mice","funder_award_id":"R01CA077429","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000285491","display_name":"Comprehensive Cancer Center Program at Fox Chase","funder_award_id":"P30CA006927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W99444931","https://openalex.org/W1488039334","https://openalex.org/W1968109047","https://openalex.org/W1968263552","https://openalex.org/W1970221409","https://openalex.org/W1977267072","https://openalex.org/W1979909416","https://openalex.org/W1987963920","https://openalex.org/W1995635189","https://openalex.org/W2011360946","https://openalex.org/W2048677309","https://openalex.org/W2053885863","https://openalex.org/W2064628234","https://openalex.org/W2089582883","https://openalex.org/W2095981921","https://openalex.org/W2097767970","https://openalex.org/W2103540939","https://openalex.org/W2109528706","https://openalex.org/W2111452131","https://openalex.org/W2113122060","https://openalex.org/W2122492252","https://openalex.org/W2127281537","https://openalex.org/W2130941707","https://openalex.org/W2134127098","https://openalex.org/W2135947389","https://openalex.org/W2137208309","https://openalex.org/W2137714688","https://openalex.org/W2160475597","https://openalex.org/W2161817637","https://openalex.org/W2163476499","https://openalex.org/W2216554257","https://openalex.org/W2388163742"],"related_works":["https://openalex.org/W2160475597","https://openalex.org/W1987963920","https://openalex.org/W1995635189","https://openalex.org/W2103540939","https://openalex.org/W1968109047","https://openalex.org/W4220745254","https://openalex.org/W2020896167","https://openalex.org/W2198939776","https://openalex.org/W2057256523","https://openalex.org/W7111884439"],"abstract_inverted_index":{"UNLABELLED:":[0],"The":[1,54,130],"aim":[2],"of":[3,11,28,42,47,57,80,114,122,132,139,161,175,215],"this":[4],"study":[5],"was":[6,33,65,82,104,134],"to":[7,92,154,190],"determine":[8],"the":[9,61,78,120,159,172],"role":[10],"AKT":[12,31,103,141,146,149,199],"as":[13,97,227,229],"a":[14,208,224,230],"therapeutic":[15,210],"target":[16,211],"in":[17,72,75,85,108,158,183,203,212,223],"ovarian":[18,29,44,68,204,216],"clear":[19],"cell":[20,70],"carcinoma":[21],"(CCC),":[22],"an":[23],"aggressive,":[24],"chemoresistant":[25],"histologic":[26],"subtype":[27],"cancer.":[30,217],"activation":[32,150],"assessed":[34],"by":[35,60],"immunohistochemistry":[36],"(IHC)":[37],"using":[38,67,84],"human":[39],"tissue":[40],"microarrays":[41],"primary":[43],"cancers,":[45],"composed":[46],"both":[48,107],"CCC":[49,69,115],"and":[50,74,110,127,151,206],"serous":[51],"adenocarcinoma":[52],"(SAC).":[53],"growth-inhibitory":[55],"effect":[56,131,174],"AKT-specific":[58],"targeting":[59],"small-molecule":[62],"inhibitor,":[63],"perifosine,":[64],"examined":[66,83],"lines":[71],"vitro":[73],"vivo.":[76],"Finally,":[77],"activity":[79,121,142,182],"perifosine":[81,118,133,155,166,178],"CCC-derived":[86,184],"tumors":[87,185],"that":[88,186,198],"had":[89,187],"acquired":[90,188],"resistance":[91,189],"anti-VEGF":[93],"or":[94,99,192,240],"chemotherapeutics":[95],"such":[96],"bevacizumab":[98,191,241],"cisplatin,":[100],"respectively.":[101],"Interestingly,":[102],"frequently":[105,201],"activated":[106,202],"early-stage":[109],"advanced-stage":[111],"CCCs.":[112],"Treatment":[113,164],"cells":[116],"with":[117,144,165,168],"attenuated":[119],"AKT-mTORC1":[123],"signaling,":[124],"inhibited":[125],"proliferation,":[126],"induced":[128],"apoptosis.":[129],"more":[135],"profound":[136],"under":[137],"conditions":[138],"high":[140],"compared":[143],"low":[145],"activity.":[147],"Increased":[148],"enhanced":[152,171],"sensitivity":[153],"were":[156],"observed":[157],"context":[160],"cisplatin-resistant":[162],"CCC.":[163],"concurrently":[167],"cisplatin":[169],"significantly":[170],"antitumor":[173,181],"cisplatin.":[176,193],"Moreover,":[177],"showed":[179],"significant":[180],"Collectively,":[194],"these":[195],"data":[196],"reveal":[197],"is":[200,207],"CCCs":[205],"promising":[209],"aggressive":[213],"forms":[214],"IMPLICATIONS:":[218],"AKT-targeted":[219],"therapy":[220],"has":[221],"value":[222],"first-line":[225],"setting":[226],"well":[228],"second-line":[231],"treatment":[232],"for":[233],"recurrent":[234],"disease":[235],"developing":[236],"after":[237],"platinum-based":[238],"chemotherapy":[239],"treatment.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}